Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Arthritis Res Ther ; 11(3): R96, 2009.
Article in English | MEDLINE | ID: mdl-19549314

ABSTRACT

INTRODUCTION: The molecular mechanisms underlying cartilage destruction in osteoarthritis are poorly understood. Proteolysis is a key feature in the turnover and degradation of cartilage extracellular matrix where the focus of research has been on the metzincin family of metalloproteinases. However, there is strong evidence to indicate important roles for other catalytic classes of proteases, with both extracellular and intracellular activities. The aim of this study was to profile the expression of the majority of protease genes in all catalytic classes in normal human cartilage and that from patients with osteoarthritis (OA) using a quantitative method. METHODS: Human cartilage was obtained from femoral heads at joint replacement for either osteoarthritis or following fracture to the neck of femur (NOF). Total RNA was purified, and expression of genes assayed using Taqman low-density array quantitative RT-PCR. RESULTS: A total of 538 protease genes were profiled, of which 431 were expressed in cartilage. A total of 179 genes were differentially expressed in OA versus NOF cartilage: eight aspartic proteases, 44 cysteine proteases, 76 metalloproteases, 46 serine proteases and five threonine proteases. Wilcoxon ranking as well as the LogitBoost-NR machine learning approach were used to assign significance to each gene, with the most highly ranked genes broadly similar using each method. CONCLUSIONS: This study is the most complete quantitative analysis of protease gene expression in cartilage to date. The data help give direction to future research on the specific function(s) of individual proteases or protease families in cartilage and may help to refine anti-proteolytic strategies in OA.


Subject(s)
Cartilage, Articular/pathology , Gene Expression Profiling/methods , ADAM Proteins/biosynthesis , ADAM Proteins/genetics , Adult , Aged , Aged, 80 and over , Cartilage, Articular/enzymology , Cartilage, Articular/physiology , Enzyme Precursors/biosynthesis , Enzyme Precursors/genetics , Female , Femur Head/enzymology , Femur Head/metabolism , Femur Head/pathology , Humans , Male , Matrix Metalloproteinases/biosynthesis , Matrix Metalloproteinases/genetics , Middle Aged , Osteoarthritis/enzymology , Osteoarthritis/metabolism , Osteoarthritis/pathology , Reverse Transcriptase Polymerase Chain Reaction
2.
Man Ther ; 13(6): 484-91, 2008 Dec.
Article in English | MEDLINE | ID: mdl-17662639

ABSTRACT

A number of studies have indicated that eccentric calf muscle training has beneficial effects in the management of Achilles tendon pain for recreational athletes. The purpose of this prospective randomised single blind pilot study was to investigate their potential effectiveness compared with therapeutic ultrasound in subjects with relatively sedentary lifestyles in an NHS hospital setting. Eleven men and five women (mean age 53+/-21 years) with Achilles tendon pain of minimum duration 4 months were randomised to one of two treatment groups; either eccentric loading or ultrasound. Administration of ultrasound and regular supervision of exercises occurred over a period of 6 weeks, with unsupervised exercises continuing for another 6 weeks. Outcome measurements were taken prior to and after 2, 4, 6 and 12 weeks after commencing treatment. They included: pain on a visual analogue scale, functional index of the leg and lower limb, and the five question EuroQol generalised health questionnaire. The difference in mean score was calculated together with 95% confidence intervals assuming a normal distribution. There were no statistically significant differences between groups or clear trends over time. In addition there was considerable overlap between the confidence intervals. This is not unexpected given the small sample size. Both interventions proved acceptable to the patients with no adverse effects. On this basis we intend conducting a full multi-centred study.


Subject(s)
Achilles Tendon/injuries , Athletic Injuries/therapy , Exercise Therapy/methods , Muscle, Skeletal , Tendinopathy/therapy , Ultrasonic Therapy , Achilles Tendon/physiopathology , Adult , Aged , Athletic Injuries/physiopathology , Female , Humans , Male , Middle Aged , Patient Satisfaction , Pilot Projects , Prospective Studies , Single-Blind Method , Tendinopathy/physiopathology , Treatment Outcome , United Kingdom , Weight-Bearing
3.
Arthritis Res Ther ; 8(4): R124, 2006.
Article in English | MEDLINE | ID: mdl-16859525

ABSTRACT

Cartilage destruction in osteoarthritis (OA) is thought to be mediated by two main enzyme families; the matrix metalloproteinases (MMPs) are responsible for cartilage collagen breakdown, whereas enzymes from the 'a disintegrin and metalloproteinase domain with thrombospondin motifs' (ADAMTS) family mediate cartilage aggrecan loss. Tissue inhibitors of metalloproteinases (TIMPs) regulate the activity of these enzymes. Although cartilage destruction in OA might be driven by the chondrocyte, low-grade synovitis is reported in patients with all grades of this disease. Our earlier work profiling these gene families in cartilage identified a number of genes that are regulated in OA, which are hence implicated in the disease process. Because the synovium might contribute to cartilage-matrix destruction in OA, we have extended the screening in the current study. We have profiled MMP, ADAMTS and TIMP genes in both cartilage and synovium from patients with either OA of the hip or a fracture to the neck of femur (NOF), giving a more complete picture of proteolysis in this disease. The four most significantly upregulated genes (P < 0.0001) in OA synovium compared to the fractured NOF are MMP28, ADAMTS16, ADAMTS17 and TIMP2. For MMP9, MMP10, MMP12, MMP17, MMP23, MMP28, ADAMTS4, and ADAMTS9, there is a significant correlation between expression levels in the synovium and cartilage, suggesting similar mechanisms of regulation. Additionally, we have shown that in cartilage the median level of steady-state mRNA for MMP13 is approximately 20-fold higher than MMP28 and approximately 1,500-fold higher than ADAMTS16, with expression of this latter gene approximately 150-fold higher in synovium than cartilage. This study is the most comprehensive analysis of the metzincin family of proteinases in the joint to date and has identified several proteinase genes not previously reported to be expressed or regulated in synovium.


Subject(s)
Cartilage, Articular/metabolism , Gene Expression Profiling , Metalloproteases/metabolism , Synovial Membrane/metabolism , Tissue Inhibitor of Metalloproteinases/metabolism , ADAM Proteins/genetics , ADAM Proteins/metabolism , ADAMTS Proteins , Aged , Aged, 80 and over , Female , Gene Expression , Hip Joint , Humans , Male , Matrix Metalloproteinase 13/genetics , Matrix Metalloproteinase 13/metabolism , Matrix Metalloproteinases, Secreted/genetics , Matrix Metalloproteinases, Secreted/metabolism , Metalloproteases/genetics , Middle Aged , Multigene Family , Protein Isoforms , Tissue Inhibitor of Metalloproteinases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...